middle.news
Xenitra Secures A$12 Million OTC Pharmaceutical Agreement With Kangsheng
8:55am on Monday 27th of July, 2026 AEST
•
Healthcare
Read Story
Xenitra Secures A$12 Million OTC Pharmaceutical Agreement With Kangsheng
8:55am on Monday 27th of July, 2026 AEST
Key Points
Three-year A$12 million procurement deal with Kangsheng
Agreement marks commercial launch of OTC pharmaceuticals division
Access to China’s large healthcare market via established distributor
Deal complements Xenitra’s nutritionals and OPAL token sales pillars
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Xenitra (ASX:XEN)
OPEN ARTICLE